ASND News Today: Stay Updated with the Latest Ascendis Pharma A/S News in Real Time
Find ASND news now at Meyka AI. Stay informed with the latest Ascendis Pharma A/S stocks updates, including price news, market analysis, and expert insights.
Concord Biotech Shares Jump 5.9% After US FDA Approves Tofacitinib Arthritis Drug
Shares of Concord Biotech saw strong buying interest after a key global development. The stock rose around 5.9% in recent trading sessions after news of a US FDA approval related to its Tofacitinib-based arthritis drug. The trigger is important. The US Food and Drug Administration (FDA) approval opens doors to the world’s largest pharmaceutical market….
Top Indian Stocks: Ajanta Pharma, Bharti Airtel, IndiGo Lead Watchlist Amid Global Market Weakness
Indian equities entered the June 10 session with caution as global markets remained under pressure from rising crude oil prices and geopolitical concerns. Despite the weak backdrop, a few key stocks stood out due to major corporate developments, regulatory relief, and ownership changes. Market participants are closely tracking Ajanta Pharma, Bharti Airtel, and IndiGo as…
GSK to Buy Nuvalent for $10.6 Billion, Paying $124 Per Share in All-Cash Deal
GSK has made a major move in the global pharmaceutical industry. The company has agreed to acquire Nuvalent for $10.6 billion in an all-cash deal. The offer price is $124 per share, which is about a 40% premium compared to the last closing price of Nuvalent. This is not a small deal. It is one…
Panacea Biotec Soars 11.89% to 52-Week High After Launch of EU-Funded DENSTAR Project
Panacea Biotec is having its best week in years. The stock surged 11.89% to a fresh 52-week high of ₹619.05 on June 9, 2026, on the NSE, rallying from a 52-week low of ₹293.10, for an 111% climb in under twelve months. The trigger was the official launch of the DENSTAR project, a 48-month, EU-backed…
NIFTY50 Plunges 0.92% on Asia Selloff, Oil Spike, June 08
NIFTY50 drops 0.92% on June 8 as Asian markets crash, crude oil spikes to $96, and geopolitical tensions in West Asia weigh on Indian equities.
Nifty 50 EPS Cuts: Cipla, L&T, Adani Enterprises & Adani Ports Among 31 Downgraded Stocks in FY27 Forecast
Earnings expectations for India’s top companies are facing fresh pressure. In May 2026, analysts lowered FY27 earnings-per-share (EPS) forecasts for 31 of the 50 companies in the Nifty 50 index, highlighting growing concerns about profit growth across key sectors. Major names such as Cipla, L&T, Adani Enterprises, and Adani Ports were among those affected. The…
Hang Seng Index Eyes 28,000 as Analysts Favor AI and Healthcare
Everbright Securities targets Hang Seng Index at 28,000 points in H2 2026, favoring AI, healthcare, and consumer stocks amid China’s policy support.
Wockhardt Shares Fall Over 8% as Investors Book Profits After 50% Rally
Shares of Wockhardt saw a sharp fall of over 8% in recent trading. The drop came right after a strong rally of nearly 50% in just a few sessions. We are seeing a classic market move here. Fast gains. Then, quick profit booking. No major negative news triggered the fall. Instead, investors simply locked in…
Swiss SMI Drops 1.75% on Iran Tensions, Pharma Stocks Fall
Swiss SMI index fell 1.75% to 13,305.40 on June 1 amid U.S.-Iran tensions. Pharma stocks dropped over 3% despite strong retail sales.